about
Rituximab for thyroid-associated ophthalmopathySurgical orbital decompression for thyroid eye diseaseRituximab for thyroid-associated ophthalmopathySurgical orbital decompression for thyroid eye diseaseDoes autoimmunity against thyroglobulin play a role in the pathogenesis of Graves' ophthalmopathy: a reviewCritical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature SearchThe evaluation and treatment of graves ophthalmopathyGraves' ophthalmopathyEstablishment of a tear protein biomarker panel differentiating between Graves' disease with or without orbitopathy.Acetazolamide and Thyroid-Associated Ophthalmopathy; a Preliminary Tested Hypothesis in a TertiaryReferral Center.Current and emerging treatment options for Graves' hyperthyroidism.Hypoxia increases adipogenesis and affects adipocytokine production in orbital fibroblasts-a possible explanation of the link between smoking and Graves' ophthalmopathy.Association of BTG2, CYR61, ZFP36, and SCD gene polymorphisms with Graves' disease and ophthalmopathy.The influence of prior hyperthyroidism on euthyroid graves' ophthalmopathy.Association between polymorphisms in the TSHR gene and Graves' orbitopathy.Risk factors associated with the severity of thyroid-associated orbitopathy in Korean patients.Thyroid associated ophthalmopathy - a reviewMarkers of inflammation and fibrosis in the orbital fat/connective tissue of patients with Graves' orbitopathy: clinical implicationsChange in quality of life after medical and surgical treatment of graves' ophthalmopathy.A difficult diagnosis: severe Graves' ophthalmolopathy.The role of oxidative stress on the pathogenesis of graves' disease.Update in pathological diagnosis of orbital infections and inflammationsGraves' ophthalmopathy: a review of immunogenetics.Graves' ophthalmopathy: state of the art and perspectives.Thyroid-associated ophthalmopathy: a practical guide to classification, natural history and management.Thyroid associated orbitopathy.Differences in Gene-Gene Interactions in Graves' Disease Patients Stratified by Age of Onset.Risk factors for development or deterioration of Graves' ophthalmopathyIncidence and clinical presentation of moderate to severe graves' orbitopathy in a Danish population before and after iodine fortification of salt.An update on medical management of Graves' ophthalmopathy.Quality of life in patients with thyroid eye disease.Relationship between Clinical and Immunological Features of Thyroid Autoimmunity and Ophthalmopathy during PregnancySerum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapyCosmetic orbital surgery.Update on advanced imaging options for thyroid-associated orbitopathy.Thyroid-associated orbitopathy: Current insights into the pathophysiology, immunology and management.Greater Efficacy of Total Thyroidectomy versus Radioiodine Therapy on Hyperthyroidism and Thyroid-Stimulating Immunoglobulin Levels in Patients with Graves' Disease Previously Treated with Antithyroid Drugs.Genotype and phenotype predictors of relapse of graves' disease after antithyroid drug withdrawalPrevalence and impact of autoimmune thyroid disease on myasthenia gravis course.Prevalence and risk factors for thyroid eye disease among Korean dysthyroid patients.
P2860
Q24202845-31BB46F8-8247-46FF-BBBE-DEDFC77A650EQ24234593-3DC785E6-EA50-45ED-8CC0-32ECF4463CC2Q24235160-74FE08FF-56AE-43FB-A0CB-FAC756EAAA4AQ24242058-E60FFCE9-528D-451B-9292-AF41FC073A30Q26776335-C6AAB713-9C08-4B6B-8D3F-46C4D1EC28A3Q26800562-BFCF4D8A-94B9-4979-85AC-9A7190B70DD1Q26862144-E9C863A0-2B36-48D0-A357-4F1FC1273294Q28274196-8D70A2A5-D951-49EE-A555-B3A5F9882BCEQ33574320-3FC92998-956B-414C-B438-4D00425AF9A9Q33597076-A4DA71C5-F5C5-46B7-AD09-958EF8B8774DQ33635029-8ACF18CD-7A36-4B03-A446-F7A3487F1FA9Q33794950-9A60ABC5-4667-43FE-87CC-83BD40D5D654Q33842343-12BDCB2D-B1F3-4E9C-9C1F-DFE21A8B7CF7Q33876359-F69C14E7-7675-4CAD-965F-5BC713B383F9Q33951536-CEE48041-B92A-4AEE-8F49-8DBC986064F5Q34200995-ABCD9E5B-E1AC-42B1-8554-EF8EF28104A0Q34220709-BD147D53-5744-412E-9227-38CF72DAA170Q34275875-BACC1E54-5E37-459D-9065-B60840E1E3F9Q34893504-808F4FC6-0E78-4B23-B36A-910E46D41AC1Q35203907-D09ED3C1-5C34-45EB-ACD6-280581C694FFQ35607571-D2DDF2EA-7735-436E-B350-252831549A99Q35646491-633D2CEE-7B13-4E07-881E-F4E0234CE724Q35731002-19195312-4283-46A3-BC9C-8FC61D2A1F1DQ35785171-40A299B4-A47C-4767-B8F5-49C1A78B53F1Q35866148-AF7ACB1F-F0AA-48BF-9B7E-AE91E2573F2FQ35919247-92677A70-6697-4585-BB0A-03044918328AQ35946146-0B96CFC3-F8D3-497D-8837-92F50756DC15Q35975724-FC267313-7EE3-4DE2-AD60-72D8CEDC2E60Q36069781-A414692B-1024-4AD5-82B7-BB0FC51ACF80Q36216631-2E0B9679-5935-48C6-B1AC-A9E574F37690Q36400185-341145D6-9517-4A16-8510-34BE6286FE99Q36423941-711A64E8-A651-4676-ADA6-399B1A714C17Q36437367-D80C437A-D19E-41A1-918E-E311083FA939Q36613501-2D8A3921-8631-4F8C-A1AE-B09E43C70823Q37060099-7636CAF2-47AC-4829-BF41-D7AA0447D72DQ37060528-59A26CA8-AD57-411B-9613-6CC07F55202DQ37290885-FDEFFFEE-FF5F-48B8-92EA-2D5A3E0C720EQ37290923-547D4AF2-F55B-4088-AF6B-43C157444914Q37339780-E4ACF1F4-BB0C-4B42-BA23-623907FDC227Q37361004-D1BF0938-2E3E-4907-AE5E-37BA9012A731
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Epidemiology and prevention of Graves' ophthalmopathy.
@ast
Epidemiology and prevention of Graves' ophthalmopathy.
@en
Epidemiology and prevention of Graves' ophthalmopathy.
@nl
type
label
Epidemiology and prevention of Graves' ophthalmopathy.
@ast
Epidemiology and prevention of Graves' ophthalmopathy.
@en
Epidemiology and prevention of Graves' ophthalmopathy.
@nl
prefLabel
Epidemiology and prevention of Graves' ophthalmopathy.
@ast
Epidemiology and prevention of Graves' ophthalmopathy.
@en
Epidemiology and prevention of Graves' ophthalmopathy.
@nl
P1433
P1476
Epidemiology and prevention of Graves' ophthalmopathy.
@en
P2093
Luigi Bartalena
Wilmar M Wiersinga
P304
P356
10.1089/105072502761016476
P577
2002-10-01T00:00:00Z